Growing Demand for Lidocaine Injections in a Range of Medical Specialities Globally

Lidocaine vial market is anticipated to grow at a significant CAGR of 9.1% during the forecast period (2024-2031). The market growth is attributed to the growing use of lidocaine injections in a range of medical specialties, including cardiology, dentistry, and dermatology. Additionally, the market for lidocaine is growing with ongoing innovation and technological developments. New technologies frequently result in better products, more effectiveness, and better client experiences, which fuel demand and expand the market.

Lidocaine is an anesthetic agent commonly used for topical anesthesia. According to the American Society of Anesthesiologists, the use of topical medications to treat neck pain is appealing in populations such as the elderly (muscle atrophy) and service members and athletes (overuse injuries), for whom the use of oral medications is limited by side effects, drug interactions, and cognitive and psychomotor impairment. The global market for topical medications is projected to increase from $4.8 billion/yr in 2021 to $7.3 billion in 2031, with anti-inflammatory drugs and lidocaine comprising the bulk of sales.

Browse the full report description of “Lidocaine Vial Market Size, Share & Trends Analysis Report by Application (Local Anesthesia, Heart Arrhythmia, Dental Procedures and Epilepsy) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/lidocaine-vial-market

Lidocaine has a narrow therapeutic index, and plasma-level monitoring is helpful for patients with hepatic impairment who are on prolonged infusions. Ideal body weight should be used instead of actual body weight for dose calculations to avoid excessively high plasma concentrations (with an absolute upper limit of 120 mg/h for lidocaine infusions.

Recent Development

• In February 2021, MERZ Aesthetics introduced the new BELOTERO BALANCE® (+) with lidocaine. BELOTERO BALANCE (+) offers the same benefits plus the advantages of a lidocaine formulation. BELOTERO BALANCE (+) is an injectable filler used to smooth moderate-to-severe etched-in facial lines and wrinkles in the lower face. It is known for blending evenly with natural skin tissue for a seamless feel with minimal tissue disruption.

Market Coverage

• The market number available for – 2023-2031

• Base year- 2023

• Forecast period- 2024-2031

• Segment Covered- 

o By Application

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- Amphastar Pharmaceuticals, Inc., Fresenius SE & Co. KGa, AHikma Pharmaceuticals, Pfizer Inc., and Viatris Inc. among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Lidocaine Vial Market Report Segment

By Application

• Local Anesthesia
• Heart Arrhythmia
• Dental Procedures
• Epilepsy

Global Lidocaine Vial Market Report Segment by Region

North America

• United States

• Canada 

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/lidocaine-vial-market